TABLE 5.
Patient feasibility outcomes for mEMA at T1 and T2.
4 weeks post-baseline (T1) n = 12 |
12 weeks post-baseline (T2) n = 12 |
|||
M (SD) | Range | M (SD) | Range | |
SUS | 75.83 (11.98) | 60–97.5 | 76.25 (13.80) | 60–95 |
CSQ-8 | 23.92 (2.99) | 19–29 | 22.75 (3.36) | 17–27 |
CSQ-8, Client Satisfaction Questionnaire-8; SUS, System Usability Scale.